Discover and read the best of Twitter Threads about #LifeScience
Most recents (6)
.@daphnezohar notes that pharma heads of R&D are leaving after ~5 years with @jaybradner, @mmammen, John Reed, Hal Barron, Rupert Vessey being recent examples. Asks @andy_plump (8 yrs @TakedaPharma) what a minimum tenure is to make an impact #BiotechHangout
In response to @daphnezohar, @andy_plump notes “There’s no way to sustain the growth that shareholders will ever be satisfied with - we tend to see short sighted decision making which is likely why we see it reflected in the tenure of R&D execs.” #BiotechHangout
Thread on #office buildings:
Office remains the asset class with the least certain future. However, not all office space is created equal. For example, life science office is in a steadier position since lab work generally can't be performed remotely. 1/n
Office remains the asset class with the least certain future. However, not all office space is created equal. For example, life science office is in a steadier position since lab work generally can't be performed remotely. 1/n
Given persistent demand to lease life science office space, occupancy rates in this specialized asset class remain quite high. As one data point, Alexandria Real Estate, a publicly traded REIT that specializes in life science office space, reported... 2/n
...occupancy rates of 95% in their North American properties in 2Q of this year: sec.gov/ix?doc=/Archiv…
Another way to compare subcategories of office assets urban or central business district (CBD) vs suburban locations. Historically... 3/n
Another way to compare subcategories of office assets urban or central business district (CBD) vs suburban locations. Historically... 3/n
@expo2020dubai starting soon with #lifescience in focus. This is the program for 🇸🇪 swecare.se/media/jo2nwrln…
Mainly the usual lifescience-blablabla.
2 proposals what @expo2020se should talk about if it were not a marketing event
Mainly the usual lifescience-blablabla.
2 proposals what @expo2020se should talk about if it were not a marketing event
Workshop 1 : evolving risks for catastrophical events harming people and trust in science if you are blinded by buzzwords like ”Regenerative Medicine” without checking science behind (trial against #Macchiatini will start april here in 🇸🇪) . Chair @LeonidSchneide1 ->
Workshop 2: risk to disrupt health-care in your capital if you foolishly believe blindly in @MichaelEPorter ’s concept of VBHC and introduce it dogmatically without taking consideration to profession, complexity in healthcare system and COI (New @KarolinskaUnsju ) Chair @annaggan
Back to work for a crucial year for UK Science, Research & Innovation & my core Missions:
🌏 ScienceSuperpower🧑🏽🔬
💥Innovation Nation👷🏼
Here are some of the Priorities in the NewYear in-tray:
1. Horizon: continue to push for UK association, alongside a bold GlobalBritain PlanB
🌏 ScienceSuperpower🧑🏽🔬
💥Innovation Nation👷🏼
Here are some of the Priorities in the NewYear in-tray:
1. Horizon: continue to push for UK association, alongside a bold GlobalBritain PlanB
2. Research Ecosystem: implementing the Nurse, Grant & Tickell Reviews of the UK Research landscape to
- improve career paths
- reduce bureaucracy
- accelerate decision-making
- boost UK global strengths in attracting top talent in
science🧬 & innovation💥
- improve career paths
- reduce bureaucracy
- accelerate decision-making
- boost UK global strengths in attracting top talent in
science🧬 & innovation💥
3. Oversee establishment of the new UK Advanced Research & Innovation Agency (ARIA) as the UK’s “Science Satellite” to ensure the UK stays on the frontline of exploring new ways of doing new science:
Mit den „Labors der Zukunft“ investiert das biopharmazeutische Unternehmen @TakedaPharma einen dreistelligen Millionenbetrag in den Standort #Wien. Es ist großartig, dass Takeda ein neues Forschungszentrum in der #Seestadt errichtet und damit seine Kräfte hier in Wien bündelt. /1
Diese erfreuliche Entwicklung zeigt: @Stadt_Wien als #LifeScience Hub ist hochgradig attraktiv für Unternehmen aus dem Forschungs- und Entwicklungsbereich. Wien will Forschung, Entwicklung und Produktion in der Stadt – und schafft dafür die Voraussetzungen. /2
Das Bekenntnis der Stadt zu #Forschung, Entwicklung und Produktion wissen auch die rund 600 Life Sciences-Unternehmen mit rund 41.000 Beschäftigten am Standort Wien zu schätzen. /3
Tacksam för feed-back till den första debattartikeln jag fick medverka i. Helst kritik och rättelse. Det är som med all vetenskap. Vi skall sluta vara ”så glittrande glada” (citat från @FiaEwald ). Klappar på axeln kommer inte driva utvecklingen framåt. #lifescience
Jag är särskild intresserad i feedback från @ottersenolep @genomicmedswe @forskasverige @LifeScienceSwe
@CancerNatverket @katarinanatverk @sallsynt @LIFetimeSE @BettinaRyll (sorry will try to send an english translation later)
@CancerNatverket @katarinanatverk @sallsynt @LIFetimeSE @BettinaRyll (sorry will try to send an english translation later)
Jag ber @ottersenolep om ursäkt att jag skrev onyanserat i en kommentar under @SvDDebatt att artikeln svd.se/snabbare-tillg… var vilseledande. Jag har lärt mig senaste veckorna vilken skillnad det är mellan att slänga ut sig nåt och att skriva en debattartikel.
